Results 141 to 150 of about 14,626,809 (402)

Heterogeneous Photocatalytic Dehydrogenative Cross‐Coupling and Addition Reaction with Metal‐Loaded Titanium Oxide Photocatalysts

Advanced Energy & Sustainability Research
Heterogeneous photocatalytic reactions begin with photoexcitation, followed by simultaneous reduction and oxidation processes that generate radical intermediates.
Hisao Yoshida
doaj   +1 more source

Effects of Plasma Power on By-Product Gas Formation from CHF₃ and CH₂F₂ Process Gases in Semiconductor Etching Processes

Applied Sciences
In semiconductor manufacturing, fluorinated gases such as CHF3 and CH2F2 are widely used as process gases for plasma etching and cleaning. However, their decomposition within the plasma environment leads to the formation of secondary fluorinated by ...
Dae Kee Min, Jiyun Woo, Joohee Lee, Bong-Jae Lee, Eui-chan Jeon   +4 more
doaj   +1 more source

Cobalt-catalyzed C–H cyanations: Insights into the reaction mechanism and the role of London dispersion

Beilstein Journal of Organic Chemistry, 2018
Carboxylate-assisted cobalt(III)-catalyzed C–H cyanations are highly efficient processes for the synthesis of (hetero)aromatic nitriles. We have now analyzed the cyanation of differently substituted 2-phenylpyridines in detail computationally by density ...
Eric Detmar, Valentin Müller, Daniel Zell, Lutz Ackermann, Martin Breugst   +4 more
doaj   +1 more source

Thermal and structural analysis of the reaction mechanisms during the preparation of activated carbon from sugarcane bagasse by urea phosphate activation

, 2023
Haifeng Zuo, Zhigao Liu
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Dynamics of Proton Transfer in Mesoscopic Clusters

, 1996
Proton transfer rates and mechanisms are studied in mesoscopic, liquid-state, molecular clusters. The proton transfer occurs in a proton-ion complex solvated by polar molecules comprising the cluster environment.
Raymond Kapral, Styliani Consta, Warshel A.   +2 more
core   +2 more sources

Identifying Beneficial and Adverse Co4+ Species in Cobalt‐Based Oxygen Evolution Catalysts via Precursor Polymorphism Engineering

Advanced Science
The oxygen evolution reaction (OER) is a critical bottleneck in water electrolysis for hydrogen production, necessitating catalysts that optimize both efficiency and cost.
Zhongheng Li, Zheng Shu, Lun Li, Wendi Zhang, Jiaqian Kang, Chengcheng Zhong, Ziwen Feng, Jinxian Feng, Hou Ian, Hui Pan   +9 more
doaj   +1 more source

Iron Redox Cycling in Persulfate Activation: Strategic Enhancements, Mechanistic Insights, and Environmental Applications—A Review

Nanomaterials
Iron-based catalysts for peroxymonosulfate (PMS) and peroxydisulfate (PDS) activation represent a cornerstone of advanced oxidation processes (AOPs) in environmental remediation, prized for their cost-effectiveness, environmental compatibility, and high ...
Zutao Zhang, Fengyang Du, Hongliang Shi, Huanzheng Du, Peiyuan Xiao   +4 more
doaj   +1 more source

Putative role of immune reactions in the mechanism of tardive dyskinesia

, 2023
A.J.M. Loonen
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source